Patterns of nerve conduction abnormalities in poems syndrome

Muscle and Nerve

Volumn 26, Issue 2, 2002, Pages 189-193

  Sung, Jia Ying ^a   Kuwabara, Satoshi ^a   Ogawara, Kazue ^a   Kanai, Kazuaki ^a   Hattori, Takamichi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Axonal degeneration; Chronic inflammatory demyelinating polyneuropathy; Demyelination; Nerve conduction study; POEMS syndrome

Indexed keywords

M PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEMYELINATING NEUROPATHY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ENDOCRINE DISEASE; FEMALE; HUMAN; MALE; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; PARAPROTEINEMIA; POLYNEUROPATHY; PRIORITY JOURNAL; SKIN DISEASE; SYNDROME DELINEATION;

ADULT; AGED; ELECTRODIAGNOSIS; FEMALE; HUMANS; MALE; MEDIAN NERVE; MIDDLE AGED; NEURAL CONDUCTION; POEMS SYNDROME; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; REACTION TIME; ULNAR NERVE;

EID: 0036331149     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10182     Document Type: Article

References (21)

1. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
2. Ultrastructural characterisation of the M protein in nerve biopsy of patients with POEMS syndrome
3. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin change: The POEMS syndrome. Report on two cases and a review of the literature
4. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome
5. Distal accentuation of conduction slowing in polyneuropathy-associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl-paraglobosides
6. Crow-Fukase syndrome
7. Long term melphalan-predonisolone chemotherapy for POEMS syndrome
8. Osteoclastic myeloma (POEMS syndrome)
9. Circulating levels of MMP-1,-2,-3,-9 and TIMP-1 are increased in POEMS syndrome
10. Plasma-cell dyscrasia with polyneuropathy: The spectrum of POEMS syndrome
11. The Crow-Fukase syndrome: A study of 102 cases in Japan
12. Axonal attenuation and secondary segmental demyelinating in myeloma neuropathies
13. Topographical differences in the vascular permeability of the peripheral nervous system
14. POEMS syndrome: Clinical, pathological, and immunological study of a case
15. Clinical spectrum of chronic acquired demyelinating polyneuropathy
16. Terminal latency index (TLI) and late response studies in motor neuron disease (MND), peripheral neuropathies and entrapment syndrome
17. Extensive demyelinating change in the peripheral nerves of Crow-Fukase syndrome: A pathological study of one autopsied case
18. Neurological manifestations of malignant and non-malignant dysglobulinaemia
19. Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin change syndrome
20. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome
21. Overproduction of vascular endothelial growth factor/vascular permeability factors is causative in Crow-Fukase (POEMS) syndrome